Response to Comments: MolDX: Predictive Classifiers for Early Stage Non-Small Cell Lung Cancer

This response-to-comments notice reports that no comments were received for MolDX LCD L38238 (comment period 2019-10-07 to 2019-11-21) and documents a title change to 'MolDX: Predictive Classifiers for Early Stage Non-Small Cell Lung Cancer.' The notice period began 2020-04-30 and the LCD became effective 2020-06-14; this document does not modify clinical coverage criteria, which remain in LCD L38238 and should be consulted for indications, limitations, documentation, and frequency rules.

"This document records the response to the comment period for MolDX LCD L38238; no provider comments were received during the comment period 2019-10-07 to 2019-11-21."

Sign up to see full coverage criteria, indications, and limitations.